Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Nurix Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arcus Biosciences Inc. June 11, 202682.4%
-
Nurix Therapeutics Inc. May 20, 202478.7%
-
Arcus Biosciences Inc. June 15, 202369.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Arcus Biosciences Inc. | Grant or award | +5,700 | — | — |
| Jun 10, 2025 | Arcus Biosciences Inc. | Grant or award | +13,300 | — | — |
| Jun 6, 2024 | Arcus Biosciences Inc. | Grant or award | +8,400 | — | — |
| Jun 15, 2023 | Arcus Biosciences Inc. | Grant or award | +6,800 | — | — |
Questions about David L. Lacey
What boards is David L. Lacey on?
David L. Lacey sits on the boards of Arcus Biosciences Inc. and Nurix Therapeutics Inc.
How long has David L. Lacey served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.